Loop Capital Boosts American Vanguard (NYSE:AVD) Price Target to $20.00

American Vanguard (NYSE:AVDGet Free Report) had its target price hoisted by equities research analysts at Loop Capital from $19.00 to $20.00 in a report issued on Monday, Benzinga reports. The firm presently has a “buy” rating on the basic materials company’s stock. Loop Capital’s target price indicates a potential upside of 67.93% from the stock’s previous close.

Other equities analysts also recently issued reports about the stock. StockNews.com upgraded shares of American Vanguard from a “hold” rating to a “buy” rating in a research note on Monday, March 18th. Roth Mkm increased their price objective on shares of American Vanguard from $13.00 to $16.00 and gave the company a “buy” rating in a research note on Friday, March 15th. Finally, Roth Capital reiterated a “buy” rating on shares of American Vanguard in a research note on Wednesday, January 31st. Four investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $18.00.

View Our Latest Stock Report on American Vanguard

American Vanguard Price Performance

Shares of NYSE AVD traded up $0.22 during mid-day trading on Monday, hitting $11.91. 27,894 shares of the company’s stock traded hands, compared to its average volume of 207,081. The company’s 50-day moving average is $11.52 and its two-hundred day moving average is $10.63. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.87 and a quick ratio of 0.92. The company has a market capitalization of $343.01 million, a P/E ratio of 44.04 and a beta of 1.00. American Vanguard has a 1 year low of $8.41 and a 1 year high of $21.60.

American Vanguard (NYSE:AVDGet Free Report) last issued its earnings results on Thursday, March 14th. The basic materials company reported $0.25 EPS for the quarter, hitting analysts’ consensus estimates of $0.25. American Vanguard had a net margin of 1.30% and a return on equity of 2.05%. The business had revenue of $172.20 million for the quarter, compared to the consensus estimate of $172.70 million. On average, equities analysts anticipate that American Vanguard will post 0.77 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in AVD. Tower Research Capital LLC TRC raised its holdings in shares of American Vanguard by 477.2% in the first quarter. Tower Research Capital LLC TRC now owns 1,166 shares of the basic materials company’s stock worth $25,000 after buying an additional 964 shares during the last quarter. CWM LLC raised its holdings in shares of American Vanguard by 492.4% in the fourth quarter. CWM LLC now owns 2,340 shares of the basic materials company’s stock worth $26,000 after buying an additional 1,945 shares during the last quarter. Captrust Financial Advisors raised its holdings in shares of American Vanguard by 85.0% during the first quarter. Captrust Financial Advisors now owns 1,417 shares of the basic materials company’s stock worth $29,000 after purchasing an additional 651 shares during the last quarter. Point72 Middle East FZE purchased a new position in shares of American Vanguard during the fourth quarter worth $31,000. Finally, Gladius Capital Management LP purchased a new position in American Vanguard in the fourth quarter valued at $37,000. Hedge funds and other institutional investors own 79.04% of the company’s stock.

American Vanguard Company Profile

(Get Free Report)

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.

Featured Articles

Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.